{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:09:55Z","timestamp":1767337795565,"version":"3.41.2"},"reference-count":6,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2021.755868","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T04:42:18Z","timestamp":1633408938000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Editorial: Tuberous Sclerosis Complex \u2013 Diagnosis and Management"],"prefix":"10.3389","volume":"12","author":[{"given":"Sergiusz","family":"Jozwiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14737175.2018.1428562","article-title":"mTOR dysregulation and tuberous sclerosis-related epilepsy","volume":"18","author":"Curatolo","year":"2018","journal-title":"Expert Rev Neurother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"107908","DOI":"10.1016\/j.neuropharm.2019.107908","article-title":"Modifying genetic epilepsies - results from studies on tuberous sclerosis complex","volume":"155","author":"Jozwiak","year":"2020","journal-title":"Neuropharmacology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/jcm8060788","article-title":"Early clinical predictors of autism spectrum disorder in infants with tuberous sclerosis complex: results from the EPISTOP study","volume":"8","author":"Moavero","year":"2019","journal-title":"J Clin Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Health."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.755868\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T04:42:19Z","timestamp":1633408939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.755868\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":6,"alternative-id":["10.3389\/fneur.2021.755868"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.755868","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"article-number":"755868"}}